L. M. Bonney, G. M. Kalisvaart, F. H. P. van Velden, K. M. Bradley, A. B. Hassan, W. Grootjans, D. R. McGowan
{"title":"Deep learning image enhancement algorithms in PET/CT imaging: a phantom and sarcoma patient radiomic evaluation","authors":"L. M. Bonney, G. M. Kalisvaart, F. H. P. van Velden, K. M. Bradley, A. B. Hassan, W. Grootjans, D. R. McGowan","doi":"10.1007/s00259-025-07149-7","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>PET/CT imaging data contains a wealth of quantitative information that can provide valuable contributions to characterising tumours. A growing body of work focuses on the use of deep-learning (DL) techniques for denoising PET data. These models are clinically evaluated prior to use, however, quantitative image assessment provides potential for further evaluation. This work uses radiomic features to compare two manufacturer deep-learning (DL) image enhancement algorithms, one of which has been commercialised, against ‘gold-standard’ image reconstruction techniques in phantom data and a sarcoma patient data set (N=20).</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>All studies in the retrospective sarcoma clinical [<span>\\(^{18}\\)</span>F]FDG dataset were acquired on either a GE Discovery 690 or 710 PET/CT scanner with volumes segmented by an experienced nuclear medicine radiologist. The modular heterogeneous imaging phantom used in this work was filled with [<span>\\(^{18}\\)</span>F]FDG, and five repeat acquisitions of the phantom were acquired on a GE Discovery 710 PET/CT scanner. The DL-enhanced images were compared to ‘gold-standard’ images the algorithms were trained to emulate and input images. The difference between image sets was tested for significance in 93 international biomarker standardisation initiative (IBSI) standardised radiomic features.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Comparing DL-enhanced images to the ‘gold-standard’, 4.0% and 9.7% radiomic features measured significantly different (p<sub>critical</sub> < 0.0005) in the phantom and patient data respectively (averaged over the two DL algorithms). Larger differences were observed comparing DL-enhanced images to algorithm input images with 29.8% and 43.0% of radiomic features measuring significantly different in the phantom and patient data respectively (averaged over the two DL algorithms).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>DL-enhanced images were found to be similar to images generated using the ‘gold-standard’ target image reconstruction method with more than 80% of radiomic features not significantly different in all comparisons across unseen phantom and sarcoma patient data. This result offers insight into the performance of the DL algorithms, and demonstrate potential applications for DL algorithms in harmonisation for radiomics and for radiomic features in quantitative evaluation of DL algorithms.</p>","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":"16 1","pages":""},"PeriodicalIF":8.6000,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Nuclear Medicine and Molecular Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00259-025-07149-7","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
PET/CT imaging data contains a wealth of quantitative information that can provide valuable contributions to characterising tumours. A growing body of work focuses on the use of deep-learning (DL) techniques for denoising PET data. These models are clinically evaluated prior to use, however, quantitative image assessment provides potential for further evaluation. This work uses radiomic features to compare two manufacturer deep-learning (DL) image enhancement algorithms, one of which has been commercialised, against ‘gold-standard’ image reconstruction techniques in phantom data and a sarcoma patient data set (N=20).
Methods
All studies in the retrospective sarcoma clinical [\(^{18}\)F]FDG dataset were acquired on either a GE Discovery 690 or 710 PET/CT scanner with volumes segmented by an experienced nuclear medicine radiologist. The modular heterogeneous imaging phantom used in this work was filled with [\(^{18}\)F]FDG, and five repeat acquisitions of the phantom were acquired on a GE Discovery 710 PET/CT scanner. The DL-enhanced images were compared to ‘gold-standard’ images the algorithms were trained to emulate and input images. The difference between image sets was tested for significance in 93 international biomarker standardisation initiative (IBSI) standardised radiomic features.
Results
Comparing DL-enhanced images to the ‘gold-standard’, 4.0% and 9.7% radiomic features measured significantly different (pcritical < 0.0005) in the phantom and patient data respectively (averaged over the two DL algorithms). Larger differences were observed comparing DL-enhanced images to algorithm input images with 29.8% and 43.0% of radiomic features measuring significantly different in the phantom and patient data respectively (averaged over the two DL algorithms).
Conclusion
DL-enhanced images were found to be similar to images generated using the ‘gold-standard’ target image reconstruction method with more than 80% of radiomic features not significantly different in all comparisons across unseen phantom and sarcoma patient data. This result offers insight into the performance of the DL algorithms, and demonstrate potential applications for DL algorithms in harmonisation for radiomics and for radiomic features in quantitative evaluation of DL algorithms.
期刊介绍:
The European Journal of Nuclear Medicine and Molecular Imaging serves as a platform for the exchange of clinical and scientific information within nuclear medicine and related professions. It welcomes international submissions from professionals involved in the functional, metabolic, and molecular investigation of diseases. The journal's coverage spans physics, dosimetry, radiation biology, radiochemistry, and pharmacy, providing high-quality peer review by experts in the field. Known for highly cited and downloaded articles, it ensures global visibility for research work and is part of the EJNMMI journal family.